Evidence map›Paper›PMID 34249931›Full record

ArticleFrontiers in cell and developmental biology2021

Zhao-Ming Xiao, Dao-Jun Lv, Yu-Zhong Yu, Chong Wang, Tao Xie, Tao Wang, Xian-Lu Song, Shan-Chao Zhao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Targeting PI3K/Akt signaling in prostate cancer therapy.Journal of cell communication and signaling · 2023
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Zhao-Ming XiaoDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Dao-Jun LvGuangdong Key Laboratory of Urology, Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Yu-Zhong YuDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Chong WangDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Tao XieDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Tao WangDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xian-Lu SongDepartment of Radiotherapy, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.
Shan-Chao ZhaoDepartment of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Nanfang Hospital · CNSouthern Medical University · CNFirst Affiliated Hospital of Guangzhou Medical University · CNGuangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily C member 1 (

methodsThe expression of

resultsOur finding showed that

conclusion

Indexed as

epithelial-mesenchymal-transitionPI3K/AKT pathwayproliferationprostate cancerSMARCC1

Identifiers

PMID34249931
PMCPMC8267926
OpenAlexW3175948364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.